Evaluation of Low-Dose Aspirin use among Critically Ill Patients with COVID-19: A Multicenter Propensity Score Matched Study.
Abdullah F Al HarthiOhoud AljuhaniGhazwa B KorayemAli F AltebainawiRaghdah S AleneziShmeylan Al HarbiJawaher GramishRaed KensaraAwattif HafidhHuda Al EnaziAhad AlawadRand AlotaibiAbdulaziz AlshehriOmar AlhuthailiRamesh VishwakarmaKhalid Bin SalehThamer AlsulaimanRahaf Ali AlqahtaniSajid HussainSaja AlmazrouKhalid Al SulaimanPublished in: Journal of intensive care medicine (2022)
Continuation of aspirin therapy during ICU stay in critically ill patients with COVID-19 who were receiving it prior to ICU admission may have a mortality benefit; nevertheless, it may be associated with an increased risk of significant bleeding. Appropriate evaluation for safety versus benefits of utilizing aspirin therapy during ICU stay in COVID19 critically ill patients is highly recommended.